Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$693.9M
+16.1% from 2023
Prescriptions
51K
$13,653.43 per claim
Patients
5,551
1,637 prescribers
Total spending, 2024
$694.2M
$125,021.93 per patient
Medicare prescription drug plans paid $693.9M for Adempas in 2024, for 50,823 prescriptions and refills to 5,551 patients (up 16.1% from 2023). The average cost per claim was $13,653.43.
Florida had the highest Medicare cost for Adempas in 2024: $56.9M for 4,141 claims, followed by Puerto Rico ($47.8M).
Hunter C Champion Sr., cardiology in Columbus, GA, had the highest Medicare cost for Adempas in 2024: 1,077 claims costing $14.9M.
Adempas is made by Bayer Aktiengesellschaft (BAYN.DE), listed in the Medicare spending data as Bayer,Pharm Div.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Hunter C Champion Sr. Columbus, GA | Cardiology | 1,077 | 110 | $14.9M |
| Alvaro U Aranda- Rodriguez Guaynabo, PR | Pulmonary Disease | 942 | 105 | $12.6M |
| John W McConnell |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,584 | 45,840 | 5,239 | $576.8M |
| 2023 | 1,531 | 44,457 | 4,975 | $597.9M |
| 2024 | 1,637 | 50,823 | 5,551 | $693.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 610 |
| 59 |
| $8.6M |
| Frank Cefali New York, NY | Nurse Practitioner | 584 | 67 | $8.0M |
| Pedro J Yapor San Juan, PR | Neurology | 566 | 57 | $7.8M |
| Murali M Chakinala Saint Louis, MO | Pulmonary Disease | 422 | 45 | $5.9M |
| Ronald Zolty Omaha, NE | Advanced Heart Failure and Transplant Cardiology | 424 | 45 | $5.8M |
| Sandeep Sahay Houston, TX | Pulmonary Disease | 393 | 39 | $5.3M |
| John Kingrey Oklahoma City, OK | Pulmonary Disease | 376 | 37 | $5.1M |
| Eric G Roberts Milwaukee, WI | Advanced Heart Failure and Transplant Cardiology | 374 | 38 | $5.0M |
| Gustavo A Heresi Davila Cleveland, OH | Pulmonary Disease | 310 | 33 | $4.3M |
| Rahul G Argula Charleston, SC | Pulmonary Disease | 315 | 36 | $4.2M |
| Ricardo Restrepo-Jaramillo Tampa, FL | Pulmonary Disease | 299 | 37 | $4.2M |
| Lori G Reed Marietta, GA | Nurse Practitioner | 299 | 38 | $4.2M |
| Kimberly C Thompson Rochester, MN | Nurse Practitioner | 299 | 32 | $4.1M |
| Paul Forfia Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 300 | 29 | $4.1M |
| Anjali Vaidya Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 276 | 27 | $3.8M |
| Elba R Martin Reyes Guaynabo, PR | Pulmonary Disease | 271 | 28 | $3.8M |
| George P Fahed Ponce, PR | Pulmonary Disease | 261 | 28 | $3.6M |
| Vallerie V McLaughlin Ann Arbor, MI | Cardiology | 264 | 26 | $3.6M |
| Chad Miller Austell, GA | Pulmonary Disease | 251 | 33 | $3.5M |
| John W Swisher Knoxville, TN | Pulmonary Disease | 254 | 30 | $3.5M |
| Therese J Sargent Phoenix, AZ | Nurse Practitioner | 248 | 32 | $3.3M |
| Adam R Bosak Glendale, AZ | Pulmonary Disease | 234 | 28 | $3.2M |
| Joseph P Stevenson Reno, NV | Cardiology | 227 | 25 | $3.1M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Bayer,Pharm Div BAYN.DE | 50,847 | $694.2M |